A Patient-Centered Approach to Managing Metastatic Gastric or GEJ Adenocarcinoma
PROGRAM DESCRIPTION Gastric cancer is among the leading causes of cancer-related deaths globally. The need for early detection and timely management is crucial because early stages of the disease are ...
Gastric cancer is among the leading causes of cancer-related deaths globally. The need for early detection and timely management is crucial because early stages of the disease are asymptomatic and initial diagnosis is often delayed. In most cases, gastric cancer is diagnosed at advanced stages with either metastatic or extensive locoregional disease. The best of a series of 5 live Grand Rounds discussing the most current challenges in managing gastric cancer is now available in an interactive, online, on-demand educational format featuring expert insight, patient case vignettes, polling questions, and peer benchmarking. This educational activity will explore the pathogenic and molecular development of gastric cancer, effective use of current and emerging treatment options, and strategies for implementing shared decision making (SDM) when treating patients with gastric cancer.
After completing this activity, the participant will demonstrate the ability to:Summarize the pathogenesis and molecular pathways involved in the development and progression of gastric cancerEvaluate the safety, efficacy, and quality of data for available and emerging targeted therapies for locally advanced or metastatic gastric and gastroesophageal junction (GEJ) adenocarcinomaIndividualize and optimize treatment with sequencing and management of treatment-related adverse events for locally advanced or metastatic gastric and GEJ adenocarcinomaEngage patients with locally advanced or metastatic gastric and GEJ adenocarcinoma in their care by implementing effective SDM strategies
I'm interested in this
Share with others
Write the first review
Share with others